ML 2-14

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

ML 2-14 is a PROTAC targeting BRD4 with a C4 alkyl linker. ML 2-14 consists of the E3 ligase ligand EN219 (HY-115715) (bule part), the target protein ligand JQ-1 (HY-13030) (red part), and the PROTAC linker (balck part). ML 2-14 can effectively degrade BRD4 in 231MFP breast cancer cells, and this effect can be reversed by the proteasome inhibitor Bortezomib (HY-10227) and the E1 activase inhibitor TAK-243 (HY-100487). ML 2-14 can be used for breast cancer-related research.
(Pink: BRD4(BD1BD2) ligand (HY-13030); Blue: E1/E2/E3 Enzyme ligand (HY-W002041); Black: linker (HY-W002041)).

For research use only. We do not sell to patients.

  • Purity: 99.43%
  • Formula: C40H38BrCl2N7O3S
  • Molecular Weight:847.65
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) ML 2-14

More

All Epigenetic Reader Domain Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00